Literature DB >> 28547118

Two Cases of Capecitabine-Induced Ileitis in Patients Treated with Radiochemotherapy to the Pelvis and Review of the Literature.

L Nicosia1, I Russo2, V De Sanctis2, G Minniti3, M Valeriani2, M F Osti2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28547118     DOI: 10.1007/s12029-017-9955-4

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  11 in total

1.  Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.

Authors:  Jun-Sang Kim; Jae-Sung Kim; Moon-June Cho; Kyu-Sang Song; Wan-Hee Yoon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

2.  Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

Authors:  Leire Arbea; Luis Isaac Ramos; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

Review 3.  Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature.

Authors:  Maha Mokrim; Philippe G Aftimos; Hassan Errihani; Martine Piccart-Gebhart
Journal:  BMJ Case Rep       Date:  2014-04-19

Review 4.  Capecitabine: an overview of the side effects and their management.

Authors:  Muhammad Wasif Saif; Nikos A Katirtzoglou; Kostas N Syrigos
Journal:  Anticancer Drugs       Date:  2008-06       Impact factor: 2.248

5.  Severe ileitis associated with capecitabine: Two case reports and review of the literature.

Authors:  Shing Fung Lee; Chi Leung Chiang; Ann Shing Lee; Frank Chi Shing Wong; Stewart Yuk Tung
Journal:  Mol Clin Oncol       Date:  2015-09-02

Review 6.  Management of rectal cancer: short- vs. long-course preoperative radiation.

Authors:  Mohammed Mohiuddin; John Marks; Gerald Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-01       Impact factor: 7.038

7.  Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.

Authors:  Ji Zhu; Fangqi Liu; Weilie Gu; Peng Lian; Weiqi Sheng; Junyan Xu; Gang Cai; Debing Shi; Sanjun Cai; Zhen Zhang
Journal:  Radiat Oncol       Date:  2014-03-07       Impact factor: 3.481

8.  Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost.

Authors:  Jun Zhao; Weigang Hu; Gang Cai; Jiazhou Wang; Jiang Xie; Jiayuan Peng; Zhen Zhang
Journal:  Oncotarget       Date:  2016-02-02

9.  Ileitis secondary to oral capecitabine treatment?

Authors:  Rami Radwan; Wanangwa C Namelo; Mark Robinson; Alison E Brewster; Gethin L Williams
Journal:  Case Rep Med       Date:  2012-11-26

10.  Capecitabine-induced terminal ileitis.

Authors:  Aboelkhair Mohammad Al-Gahmi; Ian Graham Kerr; Jamal Mohamed Zekri; Abbas Abdulqader Zagnoon
Journal:  Ann Saudi Med       Date:  2012 Nov-Dec       Impact factor: 1.526

View more
  1 in total

1.  Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.

Authors:  Artsiom Klimko; Cristian G Tieranu; Andrei O Olteanu; Carmen M Preda; Elena M Ionescu
Journal:  Cureus       Date:  2021-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.